Centrally administered neuropeptide Y fails to increase food intake but enhances hypoalgesia in spontaneously hypertensive rats

Neurosci Lett. 1993 Jan 12;149(2):209-12. doi: 10.1016/0304-3940(93)90773-e.

Abstract

The effects of intracerebroventricular (i.c.v.) administration of neuropeptide Y (NPY1-36) on food intake and pain sensitivity in hot plate test were studied in spontaneously hypertensive rats (SHRs) and in normotensive Wistar-Kyoto (WKy) rats. In satiated SHRs NPY1-36 failed to significantly increase intake at doses that produced a strong effect in satiated WKy rats (0.25-1.25 nmol). Conversely, both NPY1-36 and the C-terminal fragment NPY13-36, a putative selective agonist for the Y2-receptor for NPY, enhanced the spontaneously occurring hypoalgesia of SHRs, having no effect in WKy rats. The present results indicate that the NPY central systems involved in the control of regulatory functions are differently tuned in SHRs and WKy rats, suggesting possible involvement of these systems in the genesis of hypertension.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Eating / drug effects*
  • Injections, Intraventricular
  • Male
  • Neuropeptide Y / administration & dosage
  • Neuropeptide Y / pharmacology*
  • Pain Measurement / drug effects
  • Pain Threshold / drug effects*
  • Rats
  • Rats, Inbred SHR
  • Rats, Inbred WKY

Substances

  • Neuropeptide Y